FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 37 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $23,000 | – | 1,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 1,663,366 | $653,703 | 3.23% |
| Bleichroeder LP | 810,416 | $318,493 | 0.07% |
| Ikarian Capital, LLC | 237,553 | $93,359 | 0.02% |
| LAKE STREET ADVISORS GROUP, LLC | 739,136 | $291 | 0.02% |
| Baupost Group | 2,019,008 | $793 | 0.01% |
| Proficio Capital Partners LLC | 110,559 | $43,450 | 0.01% |
| MSD Partners, L.P. | 153,397 | $60,285 | 0.01% |
| Ballentine Partners, LLC | 143,603 | $56,436 | 0.00% |
| SVB WEALTH LLC | 253,054 | $99,450 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 18,783 | $7,382 | 0.00% |